Investigational drug for genetic form of ALS improves disease's molecular signs
An investigational drug developed to treat a rare, inherited form of amyotrophic lateral sclerosis (ALS) reduced molecular signs of the fatal, paralyzing disease and curbed neurodegeneration—but at six months, the drug ...
Sep 21, 2022
0
50